IL17A and diabetes mellitus: Therefore, healthcare professionals should pay attention to strengthening the screening of IL-17A levels in patients with diabetes mellitus and early-stage DR, and searching for drugs that effectively inhibit IL-17A levels may be an important factor in the early screening of DR and intervention in the progression of early-stage DR.